Literature DB >> 29382643

Relative survival reaches a plateau in hairy cell leukemia: a population-based analysis in The Netherlands.

Avinash G Dinmohamed1,2,3, Eduardus F M Posthuma4,5, Otto Visser6, Arnon P Kater7, Reinier A P Raymakers8, Jeanette K Doorduijn3.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29382643     DOI： 10.1182/blood-2017-12-820381

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  6 in total

1.  "Hairy Cell Leukemia (HCL): 'Real World' Outcome".

Authors:  Archit Joshi; Manikandan Dhanushkodi; Prasanth Ganesan; Venkatraman Radhakrishnan; Krishnarathinam Kannan; Nikita Mehra; Jayachandran Perumal Kalaiyarasi; S Krupashankar; Shirley Sundersingh; T S Ganesan; T G Sagar
Journal:  Indian J Hematol Blood Transfus       Date:  2019-09-28       Impact factor: 0.900

2.  Types of second primary cancers influence survival in chronic lymphocytic and hairy cell leukemia patients.

Authors:  Guoqiao Zheng; Subhayan Chattopadhyay; Amit Sud; Kristina Sundquist; Jan Sundquist; Asta Försti; Richard S Houlston; Akseli Hemminki; Kari Hemminki
Journal:  Blood Cancer J       Date:  2019-03-26       Impact factor: 11.037

3.  Adverse event rates and economic burden associated with purine nucleoside analogs in patients with hairy cell leukemia: a US population-retrospective claims analysis.

Authors:  Narendranath Epperla; Melissa Pavilack; Temitope Olufade; Richa Bashyal; Jieni Li; Shaum M Kabadi; Huseyin Yuce; Leslie Andritsos
Journal:  Orphanet J Rare Dis       Date:  2020-02-13       Impact factor: 4.123

4.  Primary therapy and survival among patients with nodular lymphocyte-predominant Hodgkin lymphoma: a population-based analysis in the Netherlands, 1993-2016.

Authors:  Hidde L A Posthuma; Josée M Zijlstra; Otto Visser; Pieternella J Lugtenburg; Marie José Kersten; Avinash G Dinmohamed
Journal:  Br J Haematol       Date:  2019-11-04       Impact factor: 6.998

Review 5.  Treatment of Classic Hairy Cell Leukemia: Targeting Minimal Residual Disease beyond Cladribine.

Authors:  Jan-Paul Bohn; Sascha Dietrich
Journal:  Cancers (Basel)       Date:  2022-02-15       Impact factor: 6.639

6.  Hairy Cell Leukemia Patients Have a Normal Life Expectancy-A 35-Year Single-Center Experience and Comparison with the General Population.

Authors:  Jan-Paul Bohn; Sabrina Neururer; Markus Pirklbauer; Andreas Pircher; Dominik Wolf
Journal:  Cancers (Basel)       Date:  2022-02-28       Impact factor: 6.639
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.